What is Juvenile-Onset Zollinger-Ellison Syndrome?
Juvenile-Onset Zollinger-Ellison Syndrome (ZES) is a rare condition in children and adolescents characterized by excessive production of stomach acid due to gastrin-secreting tumors called gastrinomas. These tumors usually develop in the pancreas or small intestine and lead to severe peptic ulcers, abdominal pain, and diarrhea.
Although ZES typically appears in adults, it can occasionally present in younger individuals, especially those with genetic syndromes like MEN1 (Multiple Endocrine Neoplasia type 1).
What Causes Juvenile-Onset Zollinger-Ellison Syndrome?
The primary cause of ZES is a gastrinoma—a type of tumor that produces excessive gastrin, a hormone that stimulates acid production in the stomach. In children, this may occur:
- Sporadically (without a family history)
- As part of MEN1, a hereditary disorder that leads to multiple endocrine tumors
The high gastrin levels result in too much stomach acid, which damages the lining of the stomach and intestines.
How Common is Juvenile-Onset ZES?
ZES is very rare in children and adolescents. Most cases are diagnosed in adults between 30 and 50 years old. In pediatric cases, it’s often discovered during investigations for unusual or severe peptic ulcers.
What Are the Symptoms of Juvenile-Onset Zollinger-Ellison Syndrome?
Children with ZES may show signs such as:
- Severe, recurring abdominal pain
- Frequent or chronic diarrhea
- Nausea and vomiting
- Heartburn or acid reflux
- Unexplained weight loss
- Peptic ulcers that don’t respond well to standard treatments
- Blood in stool or vomit (if ulcers bleed)
If MEN1 is present, the child may also have other hormonal issues or tumors in glands like the parathyroid or pituitary.
How is Juvenile-Onset Zollinger-Ellison Syndrome Diagnosed?
Diagnosis involves several tests to detect high gastrin levels and locate gastrinomas:
- Blood tests – to measure fasting serum gastrin levels
- Secretin stimulation test – to confirm ZES when gastrin levels are borderline
- Upper endoscopy – to check for ulcers or inflammation in the stomach
- Imaging tests – such as CT scan, MRI, or somatostatin receptor scintigraphy (SRS) to find tumors
- Genetic testing – for MEN1 if family history or other endocrine tumors are suspected
Early and accurate diagnosis is crucial to prevent complications.
How is Juvenile-Onset Zollinger-Ellison Syndrome Treated?
Treatment aims to control stomach acid and manage the tumor(s):
Medical Treatment:
- Proton pump inhibitors (PPIs) – like omeprazole or pantoprazole to block acid production
- H2-receptor blockers – in some cases to reduce acid
- Anti-diarrheal medications – if needed for symptom relief
Surgical Treatment:
- Surgical removal of gastrinomas – if localized and accessible
- Management of metastases – if the tumors have spread (usually to the liver)
Treatment for MEN1:
- Monitoring and treatment of other endocrine tumors as needed
- Genetic counseling for the child and family
Can Juvenile-Onset ZES Be Prevented?
There is no way to prevent sporadic ZES, but if it is associated with MEN1:
- Genetic testing and regular screenings can help detect tumors early
- Routine monitoring in children from affected families can prevent complications
What is the Outlook for a Child with ZES?
With early diagnosis and proper management, many children with ZES can lead healthy lives. However, it is a chronic condition, and treatment may be lifelong. If tumors are cancerous or spread to other organs, ongoing treatment and follow-up are necessary.
Children with MEN1 require lifelong monitoring for other tumors.
When Should You See a Doctor?
Contact a healthcare provider if your child:
- Has recurring stomach pain
- Develops peptic ulcers or severe acid reflux at a young age
- Has persistent diarrhea without explanation
- Has a family history of MEN1 or endocrine tumors
Early recognition and treatment can prevent complications.